Morepen Laboratories Limited Share Price and Company Fundamentals
Last traded: Yesterday at 10:00 AM
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Key Metrics
PE ratio
22.74
PB ratio
1.83
Dividend yield
0.49%
Beta
0.62
Market cap
₹21.83B
Enterprise value
₹22.67B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 1814 |
| Website | https://www.morepen.com |
| Mailing address | Tower C, DLF Cyber Park 2nd Floor Udyog Vihar-III, Sector-20 Gurugram 122016 India |
| Phone / Fax | 91 12 4489 2000 / |
Dividends
Dividend yield
0.49%
Dividend amount
₹0.20
Payout ratio
11.11%
5Y Avg. yield
-%
Morepen Laboratories Limited paid ₹0.20 dividend and the ex-dividend date was 29 Aug 2025.The dividend payout ratio is 11.11%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MOREPENLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Morepen Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Sushil Suri B.Sc., F.C.A. | Chairman & MD | 61 | |
| Mr. Sanjay Suri | Whole-Time Director | 57 | |
| Mr. Ajay Kumar Sharma | Chief Financial Officer | 58 | |
| Mr. Vivan Prashar | Functional Head of Operations - API | ||
| Mr. Nishant Jayesh Doshi | Vice President Corporate Finance & Investor Relations | ||
| Mr. Bhola Prasad | General Manager of Process Engineering & Technology Transfer | ||
| Ms. Sunita Suri | Manager of Administration | 31 | |
| Mr. Vipul Kumar Srivastava | Company Secretary & Compliance Officer | 40 | |
| Mr. Vikas Sharma | Functional Head of Talent Acquisition & HRBP | ||
| Ms. Amita Sharma | Chief Operating Officer of API | 59 |
Profitability and management effectiveness
Profit margin
5.57%
Operating margin
7.42%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Morepen Laboratories Limited is 21.83B and its enterprise value is 22.67B. The enterprise value to revenue ratio of MOREPENLAB is 1.27. The enterprise value to EBITDA ratio of MOREPENLAB is 22.52.
The MOREPENLAB's stocks Beta value is 0.62 making it 38% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Morepen Laboratories Limited (NSE:MOREPENLAB) Frequently Asked Questions
1. What is Morepen Laboratories Limited's Stock Symbol?
Morepen Laboratories Limited trades on NSE under the ticker symbol "MOREPENLAB".
2. What is Morepen Laboratories Limited's stock price today?
One share of MOREPENLAB stock can currently be purchased for approximately ₹39.79.
3. How can I contact Morepen Laboratories Limited?
Morepen Laboratories Limited's mailing address is Tower C, DLF Cyber Park 2nd Floor Udyog Vihar-III, Sector-20 Gurugram 122016 India. The company can be reached via phone at 91 12 4489 2000.
4. What is Morepen Laboratories Limited's official website?
The official website of Morepen Laboratories Limited is https://www.morepen.com.